MLYS vs RXRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

MLYS

51.9
AI Score
VS
RXRX Wins

RXRX

53.9
AI Score

Investment Advisor Scores

MLYS

52score
Recommendation
HOLD

RXRX

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MLYS RXRX Winner
Net Income -39.34M -644.76M MLYS
Operating Income -45.34M -648.13M MLYS
ROE -6.2% -57.0% MLYS
ROA -6.0% -43.7% MLYS
Total Assets 652.86M 1.47B RXRX
Cash 112.78M 743.29M RXRX
Current Ratio 44.33 5.50 MLYS

Relative Price Performance (Last 90 Days)

MLYS 1M: -7.0% · 3M: -12.0% RXRX 1M: -16.7% · 3M: -6.6%

Current Technical Phase

MLYS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.9%), weak momentum, RSI 41

RSI (14): 41.0 · Price: $25.74

RXRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.0 · Price: $3.17

Fundamentals Snapshot

Metric MLYS RXRX
Market Cap
Forward P/E -12.3 -3.4
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -0.6%
Gross Margin -6.5%
Operating Margin 0.0% -19.9%
EPS -1.97 -1.16
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, RXRX is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.